Last Updated:
Best Selling Drug- Mounjaro was launched in March last year. This expensive medicine has received a lot of response and sales worth Rs 333 crore were made till October alone. American company Eli Lilly makes Mounjaro, which is used in weight loss.
New Delhi. Mounjaro, a drug used in weight loss therapy made by American company Eli Lilly, has become the best-selling drug in the country. Monjaro had sales worth Rs 100 crore in the pharma retail market in October. Till now the best selling drug in the market was GSK’s antibiotic Augmentin. But, in October 2025, Mounjaro overtook it. According to Pharmatrac data, sales of Augmentin in October stood at Rs 80 crore. Monjaro is a very expensive medicine. , A month’s therapy at Mounjaro costs between Rs 14,000 to Rs 27,000. Whereas a strip of 10 tablets of Augmentin is available for just Rs 195.
This is the first time that a weight loss therapy has overtaken the country’s traditional top-selling antibiotics. The number of weight loss clinics is already increasing in economically strong cities like Mumbai and Delhi. Along with this, the spending capacity of the people there is also high. This is the reason why there is huge demand even for expensive medicines like Mounjaro. Experts say that the same trend will soon be seen in other big cities also.
Mounjaro was launched last year
Mounjaro was launched in March last year and received a good response from the beginning. Till October alone, this medicine made total sales of Rs 333 crore. Interestingly, Mounjaro is ahead in terms of sales, but Augmentin is still ahead in terms of volume i.e. units sold. In October, Augmentin sold 5,784 units, while Mounjaro sold only 85.
Glycomet-GP, which is used in the treatment of diabetes, was at third place. It sold 8,072 units in October, which is one of the highest volume drugs in the market. Despite the cost of Munjaras being expensive, the surge in sales shows that people are now resorting to expensive therapies and medicines for weight loss.
